Cyclodextrin removal of lipemic interference: An attractive alternative to ultracentrifugation for satellite laboratories

Archives of Pathology and Laboratory Medicine

Volumn 137, Issue 8, 2013, Pages 1027-1028

  Cotten, Steven W ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLODEXTRIN; LIPID;

BLOOD; BLOOD ANALYSIS; HUMAN; HYPERLIPIDEMIA; ISOLATION AND PURIFICATION; LABORATORY; LETTER; METHODOLOGY; PRECIPITATION; ULTRACENTRIFUGATION;

BLOOD CHEMICAL ANALYSIS; CHEMICAL PRECIPITATION; CYCLODEXTRINS; HUMANS; HYPERLIPIDEMIAS; LABORATORIES; LIPIDS; ULTRACENTRIFUGATION;

EID: 84881069749     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0049-LE     Document Type: Letter

References (4)

1. Bornhorst JA, Roberts RF, Roberts WL. Assayspecific differences in lipemic interference in native and intra-lipid supplemented samples. Clin Chem. 2004;50(11):2197-2201.
2. Rogers LC, Smith FA. Evaluation of LipoClear, a non-ionic polymer system for the removal of interfering lipemia [Abstract 179]. Clin Chem 1989;35:1103.
3. Klee GG, Westgard JO. Quality Management. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 5th ed. St. Louis, MO: Elsevier; 2012:198.
4. Vermeer HJ, Steen G, Naus AJM, Goevaerts B, Agricola PT, Schoemakers CHH. Correction of patient results for Beckman Coulter LX-20 assays affected by interference due to hemoglobin, bilirubin or lipids: a practical approach. Clin Chem Lab Med. 2007;45(1):114-119.